| Lipid-based |
| Doxil |
Janssen |
Kaposi’s sarcoma, ovarian cancer, multiple myeloma |
1995 |
| DaunoXome |
Galen |
Kaposi’s sarcoma |
1996 |
| AmBisome |
Gilead Sciences |
Fungal/protozoal infections |
1997 |
| Visudyne |
Bausch and Lomb |
Wet age-related macular degeneration, myopia, ocular histoplasmosis |
2000 |
| Marqibo |
Acrotech Biopharma |
Acute lymphoblastic leukaemia |
2012 |
| Onivyde |
Ipsen |
Metastatic pancreatic cancer |
2015 |
| Vyxeos |
Jazz Pharmaceuticals |
Acute myeloid leukaemia |
2017 |
| Onpattro |
Alnylam Pharmaceuticals |
Transthyretin-mediated amyloidosis |
2018 |
| Polymer-based |
| Oncaspar |
Servier Pharmaceuticals |
Acute lymphoblastic leukaemia |
1994 |
| Copaxone |
Teva |
Multiple sclerosis |
1996 |
| PegIntron |
Merck |
Hepatitis C infection |
2001 |
| Eligard |
Tolmar |
Prostate cancer |
2002 |
| Neulasta |
Amgen |
Neutropenia, chemotherapy induced |
2002 |
| Abraxane |
Celgene |
Lung cancer, metastatic breast cancer, metastatic pancreatic cancer |
2005 |
| Cimiza |
UCB |
Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis |
2008 |
| Plegridy |
Biogen |
Multiple sclerosis |
2014 |
| ADYNOVATE |
Takeda |
Haemophilia |
2015 |
| Inorganic |
| INFeD |
Allergan |
Iron-deficient anaemia |
1992 |
| DexFerrum |
American Regent |
Iron-deficient anaemia |
1996 |
| Ferrlecit |
Sanofi |
Iron deficiency in chronic kidney disease |
1999 |
| Venofer |
American Regent |
Iron deficiency in chronic kidney disease |
2000 |
| Feraheme |
AMAG |
Iron deficiency in chronic kidney disease |
2009 |
| Injectafer |
American Regent |
Iron-deficient anaemia |
2013 |
